Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister
Mandate

Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister

October 25, 2024 Employment and Benefits M&A Data protection and processing of personal data Intellectual Property Commercial Agreements

Vinge has advised Aunetic, a leading governance software specialist, in connection with the acquisition of Qnister AB (“Qnister”). The strategic acquisition enhances Aunetic’s product portfolio and strengthens its presence in the Swedish software compliance market.

Founded in 2017, Qnister is as a SaaS-company specialising in compliance software solutions, providing GDPR and whistleblowing solutions as well as services in sanctions screening and contract management to small and medium-sized enterprises in the private sector and to customers within the public sector.

The acquisition aligns with Aunetic’s goal to expand its compliance software suite and market reach, positioning Aunetic as a leading governance software group in Europe.

Vinge’s team mainly consisted of Filip Öhrner, Linus Adolfsson, Jonatan Stentorp (M&A), Emil Lindwall, Gulestan Ali (Employment), Carla Håkansson (Commercial Agreements & GDPR), Ian Jonson (IP) and Gabriella Balbo (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025